From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona’s bioscience industry has grown in recent years and by 2014 state bioscience firms employed just over 24,000 in nearly 1,300 business establishments. Four of the state’s five bioscience subsectors have contributed to its 2 percent overall employment gain since 2012, led by double-digit job growth in medical devices (up 11 percent). State academic institutions accounted for nearly $400 million in bioscience-related R&D expenditures in 2014 and NIH funding to these and other non-academic institutions totaled $150.6 million in 2015. Arizona inventors have had 1,751 patents issued in bioscience-related classes since 2012, primarily in medical and surgical devices but also in drugs and pharmaceuticals, microbiology and genetics, and in biochemistry. The state has seen a strong increase in venture capital invested in bioscience-related companies in recent years. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
Flagship Biosciences, a fast growing pharmaceutical services company based in Flagstaff, AZ, is a leading example of the power of the collaborative nature of the Arizona bioindustry.
Flagship Biosciences acquires IHCtech, a leading provider of research immunohistochemistry and histology services Combining tissue analysis with expert immunohistochemistry completes Flagship’s novel quantitative pathology approaches
Josephine Clark-Curtiss, a researcher at Arizona State University’s Biodesign Institute has been exploring new lines of attack againstMycobacterium tuberculosis, causative agent of tuberculosis.
On May 17th, we wrapped another successful AZBio Expo. Our community came together to share ideas, spotlight technologies, make connections and more. Over the last two weeks, I have been looking back as I edited hours of great videos that are full of insights shared by leaders from across our community. The last of the videos […]
- Focus On Lyme Scientific Conference and Dinner
- Paradise Valley
- AZBio Spring Reception At The Medtronic Tempe Campus
- Lyme Disease Patient Forum
- AZMN Cancer Caregivers Seminar
- Building Out the Biotech Team for Investment and Development Success